SEC Form 4 · accession 0001267602-19-000029
ALIMERA SCIENCES INC · ALIM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Holland
Officer — Chief Marketing Officer & SVP
Period of report
Jan 29, 2019
Accepted (ET)
Jan 31, 2019 · 4:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001267602
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 29, 2019 | F | 9,983 | $0.8234 | D | 156,005 | D | |
| Common Stock | Jan 30, 2019 | F | 9,983 | $0.8403 | D | 146,022 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of Restricted Stock Units. Such sale was executed pursuant to the mandatory terms of the Issuer's restricted stock unit award agreement that are intended to permit such sale to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to comply with the requirements of Rule 10b5-1(c).